CEPID CancerThera updates PET/CT equipment, now featuring AI and guided biopsy capabilities
Positron emission tomography (PET) and computed tomography (CT) are imaging exams widely used in healthcare for detailed and non-invasive internal
58 abstracts from the 18th Edwaldo Camargo Symposium and 2nd CancerThera Congress are published in the journal “Hematology, Transfusion and Cell Therapy” – issue 47
The 58 abstracts of scientific papers presented during the 18th Edwaldo Camargo Symposium and the 2nd CancerThera Congress, held simultaneously
18th Edwaldo Camargo Symposium and 2nd CancerThera Congress gather over 370 participants for updates on gastrointestinal tract tumors and Theranostics
On April 4 and 5, the Cyan Convention Center in Itupeva (SP) hosted the 18th Edwaldo Camargo Symposium and the
CEPID CancerThera and CNPEM strengthen ties for scientific collaboration
In a significant initiative for research on radiopharmaceuticals and metallopharmaceuticals, CEPID CancerThera and the Brazilian Center for Research in Energy
1st CancerThera Seminar addresses challenges and opportunities in scientific research and innovation
The 1st CancerThera Seminar: Transforming Research into Innovation, held on March 20, 2025, was an important gathering for the academic
CEPID CancerThera researchers participate in ALASBIMN 2025 Congress and celebrate Brazil’s selection as host for 2028
The city of Benito Juárez, Mexico, hosted the 30th Congress of the Latin American Association of Societies of Biology and
CEPID CancerThera researchers present studies at Precision Oncology and Personalized Medicine event for head and neck cancer in Germany
Biologist and researcher at the Cancer Genetics Laboratory (LAGECA) of the School of Medical Sciences at the University of Campinas
Principal investigator at CEPID CancerThera, Elba Etchebehere was appointed faculty member at the School of Medical Sciences of Unicamp
The University of Campinas (Unicamp) has officially appointed Dr. Elba Cristina Sá de Camargo Etchebehere to the position of Assistant
IPEN/CNEN delegation visits Unicamp to strengthen collaboration with CEPID CancerThera
On the afternoon of February 18, a delegation from the Institute for Energy and Nuclear Research (IPEN), linked to the
New CEPID CancerThera study with copper and uracil complexes shows potential against tumor and bacterial cells
Researchers at CEPID CancerThera are exploring a new path for the development of therapies for oncological tumors and bacterial infections: